Abstract results from the TURBO-NSCLC study found that patients who received upfront SRS in addition to CNS-penetrant TKI for EGFR or ALK driven NSCLC had significantly better CNS control and time to CNS progression than patients who received TKI alone. | Miao, ASCO 2024
